Company Overview

Update
Founded:
2013
Headquarters:
Paris-l'hopital
Funding:
$11M
Categories:
Biotechnology

Gecko Biomedical develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Description

Update

Gecko Biomedical is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. Gecko Biomedical is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Current Team (1)

Update

Funding Rounds (1) - $11M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    89 rue du Faubourg

    Saint Antoine

    Paris-l'hopital, 75011

    FRA

Images (1)

Update
  • 4459b06e2652a1690799de46b619cac1